Callabio Solutions

CallaBio helps biotech innovators advance from bench to IND with precision and speed. We specialize in non-clinical strategy and translational AI, supporting both emerging biotechs and large pharma with IND planning, CRO oversight, licensing readiness, and translational AI. From bioanalytics to AI-to-asset translation, we deliver flexible, high-impact solutions tailored to modern R&D challenges. Core Offerings 🔹 AI-to-IND Strategy Blueprint Mapping the path from model-generated hits to IND-enabling packages aligning experimental design, regulatory expectations, and data readiness. 🔹 Non-Clinical Gap Analysis & CRO Oversight Closing critical gaps across PK, tox, bioanalytics, and developability while managing CROs to deliver with clarity and accountability. 🔹 Translational AI Integration Bringing AI models into real-world decision-making by aligning in silico outputs with experimental workflows and clinical relevance. 🔹 Licensing-Readiness Support Preparing scientific narratives, data packages, and due diligence materials that position emerging assets for partnerships or acquisition.